Back to Search
ERIN LALLY, MD
MD
Ophthalmology Physician
NPI: 1417244831IndividualAccepts Medicare
Specialties, Licenses & Credentials
Ophthalmology PhysicianPrimary
Ophthalmology
Code: 207W00000X
201501277(NC)A143148(CA)0101259022(VA)
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
MT200176(PA)
CMS Specialties
PrimaryOPHTHALMOLOGY
Education
JEFFERSON MEDICAL COLLEGE OF THOMAS JEFFERSON UNIVERSITY
Class of 2011
Research & Publications (20)
Single-center series and systematic review of randomized controlled trials of malignancies in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis receiving anti-tumor necrosis factor alpha therapy: is there a need for more comprehensive screening procedures?
PMID 19479708·Arthritis Rheum·2009
1-meta
Characterization of apparently balanced chromosomal rearrangements from the developmental genome anatomy project.
PMID 18319076·Am J Hum Genet·2008
8-other
Disruption of neurexin 1 associated with autism spectrum disorder.
PMID 18179900·Am J Hum Genet·2008
8-other
Aggregatibacter actinomycetemcomitans leukotoxin requires beta-sheets 1 and 2 of the human CD11a beta-propeller for cytotoxicity.
PMID 17587330·Cell Microbiol·2007
7-preclinical
Outcome measurements in scleroderma: results from a delphi exercise.
PMID 17299843·J Rheumatol·2007
8-other
Actinobacillus actinomycetemcomitans leukotoxin requires lipid microdomains for target cell cytotoxicity.
PMID 16827908·Cell Microbiol·2006
8-other
Bronchiectasis in rheumatoid arthritis: report of four cases and a review of the literature--implications for management with biologic response modifiers.
PMID 16765715·Semin Arthritis Rheum·2006
5-case
Expression and characterization of a redox-sensing green fluorescent protein (reduction-oxidation-sensitive green fluorescent protein) in Arabidopsis.
PMID 16760494·Plant Physiol·2006
8-other
Development of polymyalgia rheumatica in patients with scleroderma.
PMID 16755675·J Rheumatol·2006
8-other
Minimally important difference in diffuse systemic sclerosis: results from the D-penicillamine study.
PMID 16540546·Ann Rheum Dis·2006
4-observational
Update on cyclooxygenase inhibitors: has a third COX isoform entered the fray?
PMID 16083531·Curr Med Res Opin·2005
6-review
High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial: lessons learned.
PMID 14978663·Semin Arthritis Rheum·2004
3-trial
Tumor necrosis factor alpha enhances Actinobacillus actinomycetemcomitans leukotoxin-induced HL-60 cell apoptosis by stimulating lymphocyte function-associated antigen 1 expression.
PMID 14688105·Infect Immun·2004
8-other
Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial.
PMID 12428241·Arthritis Rheum·2002
3-trial
Inhibitory effect of synthetic histatin 5 on leukotoxin from Actinobacillus actinomycetemcomitans.
PMID 12030965·Oral Microbiol Immunol·2002
8-other
Molecular cloning of the fur gene from Actinobacillus actinomycetemcomitans.
PMID 12011012·Infect Immun·2002
8-other
Maintenance of oxidative phosphorylation protects cells from Actinobacillus actinomycetemcomitans leukotoxin-induced apoptosis.
PMID 11736993·Cell Microbiol·2001
8-other
Effects of the American College of Rheumatology systemic sclerosis trial guidelines on the nature of systemic sclerosis patients entering a clinical trial.
PMID 11426017·Rheumatology (Oxford)·2001
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 2100 FOREST AVE STE 105
SAN JOSE, CA 95128 - Phone
- (408) 495-8800
Quick Facts
- NPI
- 1417244831
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 4
- Locations
- 2
- Years in Practice
- 15
- Publications
- 20
Are you this provider?
Claim Your Profile